This company has shut down. MorphImmune is no longer operating — its last tracked round was a Venture - Series Unknown in 2023.
Explore the Startup GraveyardMorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.
MorphImmune has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
MorphImmune is headquartered in West Lafayette, United States.
MorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.
MorphImmune is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MorphImmune — Funding & Investors." VCBacked, May 16, 2023, https://www.vcbacked.co/company/morphimmune. Accessed August 16, 2026.
VCBacked. (2023). MorphImmune — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/morphimmune
{{cite web |title=MorphImmune — Funding & Investors |url=https://www.vcbacked.co/company/morphimmune |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated